Why are biotech companies pivoting toward specialized outsourcing instead of doing everything in-house? The pharmaceutical world is undergoing a profound shift—one that’s less about blockbuster pills and more about tiny, complex molecules with massive therapeutic power. Peptides and oligonucleotides have emerged as the next-gen tools for treating a wide range of diseases, from...